The inflammasome accelerates radiation-induced lung inflammation and fibrosis in mice

Environmental Toxicology and Pharmacology

Volumn 39, Issue 2, 2015, Pages 917-926

  Sohn, Sung Hwa ^a   Lee, Ji Min ^a   Park, Soojin ^b   Yoo, Hyun ^a   Kang, Jeong Wook ^a   Shin, Dasom ^b   Jung, Kyung Hwa ^b   Lee, Yun Sil ^c   Cho, Jaeho ^a   Bae, Hyunsu ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Kyung Hee University   (South Korea)

^c Ewha Womans University   (South Korea)

Author keywords

Fibrosis; Inflammasome; Pneumonitis; Radiotherapy

Indexed keywords

CD68 ANTIGEN; CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR CELL ADHESION MOLECULE 1; CARRIER PROTEIN; CD68 PROTEIN, MOUSE; CIAS1 PROTEIN, MOUSE; CYTOKINE; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; EOSINOPHIL COUNT; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; IRRADIATION; LUNG FIBROSIS; LUNG LAVAGE; LUNG PARENCHYMA; LYMPHOCYTE COUNT; MOUSE; NEUTROPHIL COUNT; NONHUMAN; ONSET AGE; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INDUCED LUNG FIBROSIS; RADIATION INJURY; RADIATIONINDUCED LUNG INFLAMMATION; UPREGULATION; ANIMAL; BRONCHOALVEOLAR LAVAGE FLUID; C57BL MOUSE; CELL COUNT; CYTOLOGY; EXPERIMENTAL RADIATION INJURY; FIBROSIS; GENETICS; IMMUNOLOGY; LUNG; PATHOLOGY;

MUS;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BRONCHOALVEOLAR LAVAGE FLUID; CARRIER PROTEINS; CASPASE 1; CELL COUNT; CYTOKINES; FEMALE; FIBROSIS; INFLAMMASOMES; LUNG; MICE, INBRED C57BL; PNEUMONIA; RADIATION INJURIES, EXPERIMENTAL; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84925355101     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2015.02.019     Document Type: Article

References (58)

1. Akira S., Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4:499-511.
2. Anscher M.S., Murase T., Prescott D.M., Marks L.B., Reisenbichler H., Bentel G.C., Spencer D., Sherouse G., Jirtle R.L. Changes in plasma TGF beta levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis. Int. J. Radiat. Oncol. Biol. Phys. 1994, 30:671-676.
3. Barnes P.J. The cytokine network in asthma and chronic obstructive pulmonary disease. J. Clin. Invest. 2008, 118:3546-3556.
4. Barnes P.J. Immunology of asthma and chronic obstructive pulmonary disease. Nat. Rev. Immunol. 2008, 8:183-192.
5. Basak C., Pathak S.K., Bhattacharyya A., Mandal D., Pathak S., Kundu M. NF-kappaB- and C/EBPbeta-driven interleukin-1beta gene expression and PAK1-mediated caspase-1 activation play essential roles in interleukin-1beta release from Helicobacter pylori lipopolysaccharide-stimulated macrophages. J. Biol. Chem. 2005, 280:4279-4288.
6. Bousquet J., Clark T.J., Hurd S., Khaltaev N., Lenfant C., O'Byrne P., Sheffer A. GINA guidelines on asthma and beyond. Allergy 2007, 62:102-112.
7. Burge P.S., Lewis S.A. So inhaled steroids slow the rate of decline of FEV1 in patients with COPD after all?. Thorax 2003, 58:911-913.
8. Calverley P.M., Boonsawat W., Cseke Z., Zhong N., Peterson S., Olsson H. Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease. Eur. Respir. J. 2003, 22:912-919.
9. Cheever A.W., Williams M.E., Wynn T.A., Finkelman F.D., Seder R.A., Cox T.M., Hieny S., Caspar P., Sher A. Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. J. Immunol. 1994, 153:753-759.
10. Chiaramonte M.G., Donaldson D.D., Cheever A.W., Wynn T.A. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J. Clin. Invest. 1999, 104:777-785.
11. Davis B.K., Wen H., Ting J.P. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu. Rev. Immunol. 2011, 29:707-735.
12. de Torres J.P., Pinto-Plata V., Casanova C., Mullerova H., Cordoba-Lanus E., Muros de Fuentes M., Aguirre-Jaime A., Celli B.R. C-reactive protein levels and survival in patients with moderate to very severe COPD. Chest 2008, 133:1336-1343.
13. Demaria S., Pikarsky E., Karin M., Coussens L.M., Chen Y.C., El-Omar E.M., Trinchieri G., Dubinett S.M., Mao J.T., Szabo E., Krieg A., Weiner G.J., Fox B.A., Coukos G., Wang E., Abraham R.T., Carbone M., Lotze M.T. Cancer and inflammation: promise for biologic therapy. J. Immunother. 2010, 33:335-351.
14. Dhillon T., Mauri F.A., Bellezza G., Cagini L., Barbareschi M., North B.V., Seckl M.J. Overexpression of the mammalian target of rapamycin: a novel biomarker for poor survival in resected early stage non-small cell lung cancer. J. Thorac. Oncol. 2010, 5:314-319.
15. Diamond M.S., Staunton D.E., Marlin S.D., Springer T.A. Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell 1991, 65:961-971.
16. Ding N.H., Li J.J., Sun L.Q. Molecular mechanisms and treatment of radiation-induced lung fibrosis. Curr. Drug Targets 2013, 14:1347-1356.
17. dos Santos G., Kutuzov M.A., Ridge K.M. The inflammasome in lung diseases. Am. J. Physiol. Lung Cell. Mol. Physiol. 2012, 303:L627-L633.
18. Ghayur T., Banerjee S., Hugunin M., Butler D., Herzog L., Carter A., Quintal L., Sekut L., Talanian R., Paskind M., Wong W., Kamen R., Tracey D., Allen H. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 1997, 386:619-623.
19. Graves P.R., Siddiqui F., Anscher M.S., Movsas B. Radiation pulmonary toxicity: from mechanisms to management. Semin. Radiat. Oncol. 2010, 20:201-207.
20. Hasegawa M., Fujimoto M., Takehara K., Sato S. Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis. J. Dermatol. Sci. 2005, 39:1-7.
21. Hitzler I., Sayi A., Kohler E., Engler D.B., Koch K.N., Hardt W.D., Muller A. Caspase-1 has both proinflammatory and regulatory properties in Helicobacter infections, which are differentially mediated by its substrates IL-1beta and IL-18. J. Immunol. 2012, 188:3594-3602.
22. Hong Z.Y., Eun S.H., Park K., Choi W.H., Lee J.I., Lee E.J., Lee J.M., Story M.D., Cho J. Development of a small animal model to simulate clinical stereotactic body radiotherapy-induced central and peripheral lung injuries. J. Radiat. Res. 2014, 55:648-657.
23. Hurst J.R., Donaldson G.C., Perera W.R., Wilkinson T.M., Bilello J.A., Hagan G.W., Vessey R.S., Wedzicha J.A. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2006, 174:867-874.
24. Hurst J.R., Perera W.R., Wilkinson T.M., Donaldson G.C., Wedzicha J.A. Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2006, 173:71-78.
25. Jublanc C., Beaudeux J.L., Aubart F., Raphael M., Chadarevian R., Chapman M.J., Bonnefont-Rousselot D., Bruckert E. Serum levels of adhesion molecules ICAM-1 and VCAM-1 and tissue inhibitor of metalloproteinases, TIMP-1, are elevated in patients with autoimmune thyroid disorders: relevance to vascular inflammation. Nutr. Metab. Cardiovasc. Dis. 2011, 21:817-822.
26. Kelly P., Balter P.A., Rebueno N., Sharp H.J., Liao Z., Komaki R., Chang J.Y. Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation. Int. J. Radiat. Oncol. Biol. Phys. 2010, 78:1387-1393.
27. Kim D.J., Park J.H., Franchi L., Backert S., Nunez G. The Cag pathogenicity island and interaction between TLR2/NOD2 and NLRP3 regulate IL-1beta production in Helicobacter pylori infected dendritic cells. Eur. J. Immunol. 2013, 43:2650-2658.
28. Kong F.M., Ten Haken R., Eisbruch A., Lawrence T.S. Non-small cell lung cancer therapy-related pulmonary toxicity: an update on radiation pneumonitis and fibrosis. Semin. Oncol. 2005, 32:S42-S54.
29. Kostura M.J., Tocci M.J., Limjuco G., Chin J., Cameron P., Hillman A.G., Chartrain N.A., Schmidt J.A. Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:5227-5231.
30. Kuhn C., Homer R.J., Zhu Z., Ward N., Flavell R.A., Geba G.P., Elias J.A. Airway hyperresponsiveness and airway obstruction in transgenic mice. Morphologic correlates in mice overexpressing interleukin (IL)-11 and IL-6 in the lung. Am. J. Respir. Cell Mol. Biol. 2000, 22:289-295.
31. Lawrence C.E., Paterson J.C., Wei X.Q., Liew F.Y., Garside P., Kennedy M.W. Nitric oxide mediates intestinal pathology but not immune expulsion during Trichinella spiralis infection in mice. J. Immunol. 2000, 164:4229-4234.
32. Lee J.C., Kinniry P.A., Arguiri E., Serota M., Kanterakis S., Chatterjee S., Solomides C.C., Javvadi P., Koumenis C., Cengel K.A., Christofidou-Solomidou M. Dietary curcumin increases antioxidant defenses in lung, ameliorates radiation-induced pulmonary fibrosis, and improves survival in mice. Radiat. Res. 2010, 173:590-601.
33. Li M.O., Wan Y.Y., Sanjabi S., Robertson A.K., Flavell R.A. Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol. 2006, 24:99-146.
34. MacMicking J., Xie Q.W., Nathan C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 1997, 15:323-350.
35. Mariathasan S., Monack D.M. Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat. Rev. Immunol. 2007, 7:31-40.
36. Marks L.B., Yu X., Vujaskovic Z., Small W., Folz R., Anscher M.S. Radiation-induced lung injury. Semin. Radiat. Oncol. 2003, 13:333-345.
37. Martinon F., Burns K., Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 2002, 10:417-426.
38. Masoli M., Fabian D., Holt S., Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004, 59:469-478.
39. Mehta V. Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention. Int. J. Radiat. Oncol. Biol. Phys. 2005, 63:5-24.
40. Meneghin A., Hogaboam C.M. Infectious disease, the innate immune response, and fibrosis. J. Clin. Invest. 2007, 117:530-538.
41. Pazdrak K., Young T.W., Straub C., Stafford S., Kurosky A. Priming of eosinophils by GM-CSF is mediated by protein kinase CbetaII-phosphorylated l-plastin. J. Immunol. 2011, 186:6485-6496.
42. Pfister D.G., Johnson D.H., Azzoli C.G., Sause W., Smith T.J., Baker S., Olak J., Stover D., Strawn J.R., Turrisi A.T., Somerfield M.R., American Society of Clinical Oncology American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J. Clin. Oncol. 2004, 22:330-353.
43. Provatopoulou X., Athanasiou E., Gounaris A. Predictive markers of radiation pneumonitis. Anticancer Res. 2008, 28:2421-2432.
44. Reiman R.M., Thompson R.W., Feng C.G., Hari D., Knight R., Cheever A.W., Rosenberg H.F., Wynn T.A. Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity. Infect. Immun. 2006, 74:1471-1479.
45. Schaue D., McBride W.H. Links between innate immunity and normal tissue radiobiology. Radiat. Res. 2010, 173:406-417.
46. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140:821-832.
47. Sohn S.H., Jang H., Kim Y., Jang Y.P., Cho S.H., Jung H., Jung S., Bae H. The effects of Gamijinhae-tang on elastase/lipopolysaccharide-induced lung inflammation in an animal model of acute lung injury. BMC Complement. Altern. Med. 2013, 13:176.
48. Stoecklein V.M., Osuka A., Ishikawa S., Lederer M.R., Wanke-Jellinek L., Lederer J.A. Radiation exposure induces inflammasome pathway activation in immune cells. J. Immunol. 2015, 194:1178-1189.
49. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
50. Tamimi A., Serdarevic D., Hanania N.A. The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications. Respir. Med. 2012, 106:319-328.
51. Tsoutsou P.G., Koukourakis M.I. Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research. Int. J. Radiat. Oncol. Biol. Phys. 2006, 66:1281-1293.
52. Wilkinson T.M., Hurst J.R., Perera W.R., Wilks M., Donaldson G.C., Wedzicha J.A. Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD. Chest 2006, 129:317-324.
53. Wynn T.A. IL-13 effector functions. Annu. Rev. Immunol. 2003, 21:425-456.
54. Wynn T.A. Cellular and molecular mechanisms of fibrosis. J. Pathol. 2008, 214:199-210.
55. Wynn T.A., Cheever A.W., Jankovic D., Poindexter R.W., Caspar P., Lewis F.A., Sher A. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 1995, 376:594-596.
56. Yamashita H., Nakagawa K., Nakamura N., Koyanagi H., Tago M., Igaki H., Shiraishi K., Sasano N., Ohtomo K. Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors. Radiat. Oncol. 2007, 2:21.
57. Yang J.C., Yang H.C., Shun C.T., Wang T.H., Chien C.T., Kao J.Y. Catechins and sialic acid attenuate Helicobacter pylori-triggered epithelial caspase-1 activity and eradicate Helicobacter pylori infection. Evid. Based Complement. Alternat. Med. 2013, 2013:248585.
58. Yende S., Waterer G.W., Tolley E.A., Newman A.B., Bauer D.C., Taaffe D.R., Jensen R., Crapo R., Rubin S., Nevitt M., Simonsick E.M., Satterfield S., Harris T., Kritchevsky S.B. Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax 2006, 61:10-16.